Katon W, Ries R
J Fam Pract. 1983 Jul;17(1):99-102, 107-8, 111-4, passim.
The diagnostic criteria for schizophrenia have been extensively changed by the third edition of the Diagnostic and Statistical Manual of Mental Disorders, recently adopted by the American Psychiatric Association (DSM III). To receive this diagnosis, the patient must have onset of illness before age 45 years, have had a chronic course, manifest the presence of characteristic symptoms, such as delusions, hallucinations, or loose associations during a phase of the illness, and have experienced a downhill social and vocational course; affective disorders and organic brain syndrome must be carefully excluded. The utilization of this "narrow" definition has caused a major shift toward increasing the diagnosis of affective disorders and decreasing the diagnosis of schizophrenia in the United States. The etiology of schizophrenia is still uncertain, but recent research has elucidated one subgroup of schizophrenic patients who have subtle indices of neurological damage and a clinical course similar to that found in dementia. Dopamine excess in the mesolimbic system is the predominant inferred cause for the majority of schizophrenia cases, and antipsychotic medications all rely on dopamine receptor blockade for their efficacy. Antipsychotic medications are effective in schizophrenia but are less potent against such negative symptoms as apathy, neglect of personal hygiene, and social withdrawal.
美国精神病学协会最近采用的《精神疾病诊断与统计手册》第三版(DSM-III)对精神分裂症的诊断标准进行了广泛修改。要获得该诊断,患者必须在45岁之前发病,病程呈慢性,在疾病的某个阶段出现诸如妄想、幻觉或思维散漫等特征性症状,并且经历社会和职业状况的恶化;必须仔细排除情感障碍和器质性脑综合征。在美国,这种“狭义”定义的使用导致了诊断倾向的重大转变,即情感障碍的诊断增加,而精神分裂症的诊断减少。精神分裂症的病因仍然不确定,但最近的研究已经阐明了一类精神分裂症患者,他们有轻微的神经损伤指标,临床病程与痴呆症相似。中脑边缘系统多巴胺过量是大多数精神分裂症病例的主要推测病因,所有抗精神病药物的疗效都依赖于多巴胺受体阻断。抗精神病药物对精神分裂症有效,但对诸如冷漠、忽视个人卫生和社交退缩等阴性症状的效力较弱。